← All Sponsors
SPONSOR

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Healthy Postmenopausal Women
NCT07118085 Phase 1
Recruiting

A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMC-003 for Injection in Healthy Postmenopausal Women

Healthy Postmenopausal Women
China View Trial →